scholarly journals Dysfunctional Attitudes and Anxiety Sensitivity in the Manifestation and First Onset of Social Anxiety Disorder versus Specific Phobia and Healthy: A Prospective Longitudinal Study

Psychology ◽  
2016 ◽  
Vol 07 (14) ◽  
pp. 1810-1823 ◽  
Author(s):  
Myriam Rudaz ◽  
Eni S. Becker ◽  
Jürgen Margraf ◽  
Thomas Ledermann ◽  
Andrea H. Meyer ◽  
...  
Keyword(s):  
Longitudinal Study ◽  
Anxiety Disorder ◽  
Social Anxiety ◽  
Social Anxiety Disorder ◽  
Anxiety Sensitivity ◽  
Specific Phobia ◽  
Dysfunctional Attitudes ◽  
Prospective Longitudinal Study ◽  
First Onset ◽  
Prospective Longitudinal

Pharmacological Treatments for Panic Disorder, Generalized Anxiety Disorder, Specific Phobia, and Social Anxiety Disorder

2015 ◽  
Author(s):  
Ryan J. Kimmel ◽  
Peter P. Roy-Byrne ◽  
Deborah S. Cowley
Keyword(s):  
Anxiety Disorder ◽  
Social Anxiety ◽  
Panic Disorder ◽  
Generalized Anxiety Disorder ◽  
Social Anxiety Disorder ◽  
Selective Serotonin Reuptake Inhibitors ◽  
Specific Phobia ◽  
Generalized Anxiety ◽  
Pharmacological Treatments ◽  
First Line

Selective serotonin reuptake inhibitors (SSRIs) are the first-line pharmacological treatment for panic disorder based on their low rate of side effects, lack of dietary restrictions, and absence of tolerance. SSRIs and venlafaxine are attractive first-line treatments for social anxiety disorder. Pharmacological treatments of choice for generalized anxiety disorder are buspirone and antidepressants, including SSRIs and venlafaxine. Benzodiazepines, although effective for all these disorders, lack efficacy for comorbid depression and carry the risk of physiological dependence and withdrawal symptoms. Their greatest utility seems to be as an initial or adjunctive medication for patients with disabling symptoms requiring rapid relief and for those unable to tolerate other medications. Chronic treatment with benzodiazepines is generally safe and effective but should probably be reserved for patients nonresponsive or intolerant to other agents. Larger trials are necessary to determine whether pharmacological agents might be useful as monotherapies, or adjuncts to exposure psychotherapy, for specific phobia.

Recognition of irrationality of fear and the diagnosis of social anxiety disorder and specific phobia in adults: Implications for criteria revision in DSM-5

2010 ◽  
Vol 27 (11) ◽  
pp. 1044-1049 ◽  
Author(s):  
Mark Zimmerman ◽  
Kristy Dalrymple ◽  
Iwona Chelminski ◽  
Diane Young ◽  
Janine N. Galione
Keyword(s):  
Anxiety Disorder ◽  
Social Anxiety ◽  
Social Anxiety Disorder ◽  
Specific Phobia ◽  
Dsm 5

scholarly journals A cognitive-behavior therapy applied to a social anxiety disorder and a specific phobia, case study

2014 ◽  
Vol 2 (3) ◽  
Author(s):  
George D. Tsitsas ◽  
Antonia A. Paschali
Keyword(s):  
Anxiety Disorder ◽  
Social Anxiety ◽  
Social Anxiety Disorder ◽  
Behavior Therapy ◽  
Cognitive Behavior Therapy ◽  
Tall Buildings ◽  
Specific Phobia ◽  
Panic Attacks ◽  
Cognitive Behavior ◽  
University Counseling

George, a 23-year-old Greek student, was referred by a psychiatrist for treatment to a University Counseling Centre in Athens. He was diagnosed with social anxiety disorder and specific phobia situational type. He was complaining of panic attacks and severe symptoms of anxiety. These symptoms were triggered when in certain social situations and also when travelling by plane, driving a car and visiting tall buildings or high places. His symptoms lead him to avoid finding himself in such situations, to the point that it had affected his daily life. George was diagnosed with social anxiety disorder and with specific phobia, situational type (in this case acrophobia) and was given 20 individual sessions of cognitive-behavior therapy. Following therapy, and follow-up occurring one month post treatment, George no longer met the criteria for social phobia and symptoms leading to acrophobia were reduced. He demonstrated improvements in many areas including driving a car in and out of Athens and visiting tall buildings.

scholarly journals The moderating role of avoidance behavior on anxiety over time: Is there a difference between social anxiety disorder and specific phobia?

PLoS ONE ◽  
2017 ◽  
Vol 12 (7) ◽  
pp. e0180298 ◽  
Author(s):  
Myriam Rudaz ◽  
Thomas Ledermann ◽  
Jürgen Margraf ◽  
Eni S. Becker ◽  
Michelle G. Craske
Keyword(s):  
Anxiety Disorder ◽  
Social Anxiety ◽  
Social Anxiety Disorder ◽  
Avoidance Behavior ◽  
Specific Phobia ◽  
Moderating Role ◽  
Over Time

scholarly journals Children with a Specific Phobia do better in Individual CBT than Group CBT and guided parent-led CBT

2018 ◽  
Keyword(s):  
Health Care ◽  
Anxiety Disorder ◽  
Social Anxiety ◽  
Social Anxiety Disorder ◽  
Separation Anxiety ◽  
Specific Phobia ◽  
Separation Anxiety Disorder ◽  
Generalised Anxiety Disorder ◽  
Health Care Settings ◽  
Group Cbt

Children often present to health care settings with highly impairing and disabling anxiety disorders, including Specific Phobia, Social Anxiety Disorder, Generalised Anxiety Disorder and Separation Anxiety Disorder.

Specific Phobia and Social Anxiety Disorder

2018 ◽  
pp. 242-265
Author(s):  
Karen Rowa ◽  
Randi E. McCabe ◽  
Martin M. Antony
Keyword(s):  
Anxiety Disorder ◽  
Social Anxiety ◽  
Anxiety Disorders ◽  
Social Anxiety Disorder ◽  
Monitoring And Evaluation ◽  
Specific Phobia ◽  
Negative Evaluation ◽  
Assessment Instruments ◽  
And Performance ◽  
The Individual

Specific phobia and social anxiety disorder (SAD) share a number of features, but the focus of fear distinguishes between these anxiety disorders. In specific phobia, the excessive fear is focused on a particular situation or object, whereas in SAD, it is focused on one or more social and performance situations in which the individual fears acting in a way that will be embarrassing or lead to negative evaluation by others or revealing unbecoming personal attributes. The chapter focuses on the assessment of specific phobia and SAD in adults. It begins with a review of the nature of the disorders, which is followed by a review of clinical assessment instruments designed for the assessment purposes of (a) diagnosis, (b) case conceptualization and treatment planning, and (c) treatment monitoring and evaluation. Recommendations are included for instruments with the greatest scientific support and for assessing these anxiety disorders in a clinically sensitive manner.

Sign in / Sign up

Export Citation Format

Share Document